Sprinklr Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Sprinklr has a total shareholder equity of $469.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $983.8M and $514.8M respectively. Sprinklr's EBIT is $37.3M making its interest coverage ratio -4.5. It has cash and short-term investments of $468.5M.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı-4.5x
NakitUS$468.45m
EşitlikUS$468.97m
Toplam yükümlülüklerUS$514.83m
Toplam varlıklarUS$983.80m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Lacklustre Performance Is Driving Sprinklr, Inc.'s (NYSE:CXM) Low P/S

Nov 03
Lacklustre Performance Is Driving Sprinklr, Inc.'s (NYSE:CXM) Low P/S

Sprinklr: Sales Missteps Shouldn't Prevent You From Buying This Tremendous Value Stock

Sep 30

Sprinklr: Still Waiting For Signs Of Growth Inflection

Sep 17

A Look At The Fair Value Of Sprinklr, Inc. (NYSE:CXM)

Aug 29
A Look At The Fair Value Of Sprinklr, Inc. (NYSE:CXM)

Sprinklr (NYSE:CXM) Is Looking To Continue Growing Its Returns On Capital

Aug 01
Sprinklr (NYSE:CXM) Is Looking To Continue Growing Its Returns On Capital

Sprinklr: Rebound Software Stock Trading At Bargain Multiples

Jul 18

Sprinklr's Earnings Miss Points Toward An Extended And Uncertain Turnaround Period

Jun 17

Sprinklr, Inc. (NYSE:CXM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Jun 13
Sprinklr, Inc. (NYSE:CXM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Sprinklr Q1 Earnings: Painful Transition Continues As Macro Headwinds Increase

Jun 07

Sprinklr, Inc.'s (NYSE:CXM) Business Is Trailing The Industry But Its Shares Aren't

Apr 25
Sprinklr, Inc.'s (NYSE:CXM) Business Is Trailing The Industry But Its Shares Aren't

Sprinklr: Strong AI Tailwinds And Decent Valuation

Apr 01

Sprinklr, Inc.'s (NYSE:CXM) Intrinsic Value Is Potentially 55% Above Its Share Price

Mar 25
Sprinklr, Inc.'s (NYSE:CXM) Intrinsic Value Is Potentially 55% Above Its Share Price

Is Now The Time To Look At Buying Sprinklr, Inc. (NYSE:CXM)?

Mar 04
Is Now The Time To Look At Buying Sprinklr, Inc. (NYSE:CXM)?

Sprinklr: Near-Term Growth Weakness Is Not Structural

Jan 09

Risks Still Elevated At These Prices As Sprinklr, Inc. (NYSE:CXM) Shares Dive 32%

Jan 04
Risks Still Elevated At These Prices As Sprinklr, Inc. (NYSE:CXM) Shares Dive 32%

There's Been No Shortage Of Growth Recently For Sprinklr's (NYSE:CXM) Returns On Capital

Dec 29
There's Been No Shortage Of Growth Recently For Sprinklr's (NYSE:CXM) Returns On Capital

Taking A Bite Into Sprinklr's Q3 Mud Sandwich

Dec 28

Sprinklr Shocks The Market With Preliminary Fiscal 2025 Expectations

Dec 07

Calculating The Fair Value Of Sprinklr, Inc. (NYSE:CXM)

Dec 06
Calculating The Fair Value Of Sprinklr, Inc. (NYSE:CXM)

Buy Sprinklr's AI In Customer Experience Management And Robust Market Growth

Nov 30

Is Sprinklr, Inc. (NYSE:CXM) Potentially Undervalued?

Oct 14
Is Sprinklr, Inc. (NYSE:CXM) Potentially Undervalued?

Sprinklr: Expecting Revenue To Regain Momentum

Sep 19

Sprinklr, Inc.'s (NYSE:CXM) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 22
Sprinklr, Inc.'s (NYSE:CXM) Intrinsic Value Is Potentially 59% Above Its Share Price

Sprinklr Shows Large Customer Growth As Operating Breakeven Nears

Aug 10

At US$14.30, Is Sprinklr, Inc. (NYSE:CXM) Worth Looking At Closely?

Jul 12
At US$14.30, Is Sprinklr, Inc. (NYSE:CXM) Worth Looking At Closely?

Sprinklr: Subscription Business Humming In Fiscal Q1 2024

Jun 06

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CXM's short term assets ($741.6M) exceed its short term liabilities ($459.3M).

Uzun Vadeli Yükümlülükler: CXM's short term assets ($741.6M) exceed its long term liabilities ($55.5M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CXM is debt free.

Borcun Azaltılması: CXM had no debt 5 years ago.

Borç Kapsamı: CXM has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: CXM has no debt, therefore coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin